Previous studies in miniature swine have demonstrated that products of the class II region of the major histocompatibility complex (MHC) are of overwhelming importance in determining the fate of vascularized allografts, and it is likely that the same is true in human beings. In addition, it has recently been demonstrated in a mouse model that reconstitution of myeloablated animals with syngeneic bone marrow cells, transduced with an allogeneic MHC gene leads to specific prolongation of survival of skin grafts bearing the same alloantigen. In preliminary studies, the transfer of class II genes by bone marrow transplantation from an intra-MHC recombinant donor, led to long-term tolerance to a subsequent renal allograft class II matched to the bone marrow donor but completely mismatched to the recipient. Taken together, these results suggest that transfer of genes encoding class II antigens could provide a new approach to the induction of specific transplantation tolerance across complete histocompatibility barriers. The overall goal of this project is to introduce allogeneic class II genes into autologous bone marrow cells of miniature swine via retroviral transduction and to determine the effects of this procedure on parameters of transplantation immunity. cDNA clones corresponding to all expressed class II genes from two SLA haplotypes have previously been isolated and sequenced in this laboratory.
The specific aims of this proposal are to: 1) Construct recombinant retroviruses containing SLA class II cDNAs under the transcriptional control of constitutive promoters; 2) Establish conditions for introduction of allogeneic class II genes into bone marrow stem cells via these recombinant retroviral vectors; 3) Reconstitute myeloablated miniature swine with autologous bone marrow cells transduced with allogeneic class II cDNAs, and examine the expression of the introduced genes; and 4) Determine the effects of class II gene transfer on the induction of transplantation tolerance as detected by in vitro and in vivo assays. These studies could have important implications for the use of gene transfer technology in the manipulation of immune responses to both allogeneic and xenogeneic transplants in the future.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI033053-01
Application #
3148171
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1992-07-01
Project End
1997-04-30
Budget Start
1992-07-01
Budget End
1993-04-30
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Matter-Reissmann, Ulrike B; Sonntag, Kai-Christian; Gilli, Urs O et al. (2004) Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity. Xenotransplantation 11:43-52
LeGuern, Christian (2003) Regulation of T-cell functions by MHC class II self-presentation. Trends Immunol 24:633-8
Shimada, Hideaki; Germana, Sharon; Hayashi, Hideki et al. (2003) Expression of MHC class II DQ alpha/beta heterodimers from recombinant polycistronic retroviral genomes. Surg Today 33:183-9
Denaro, Maria; Kolber-Simonds, Donna; Schad, Victoria et al. (2002) Expression of xenogeneic MHC class II molecules in HLA-DR(+) and -DR(-) cells: influence of retrovirus vector design and cellular context. Xenotransplantation 9:115-24
Baron, C; Sachs, D H; LeGuern, C (2001) A particular TCR beta variable region used by T cells infiltrating kidney transplants. J Immunol 166:2589-96
Seebach, J D; Schneider, M K; Comrack, C A et al. (2001) Immortalized bone-marrow derived pig endothelial cells. Xenotransplantation 8:48-61
Salmon, H; Johnson, I; Germana, S et al. (2000) Dendritic cells enriched from swine thymus co-express CD1, CD2 and major histocompatibility complex class II and actively stimulate alloreactive T lymphocytes. Scand J Immunol 52:164-72
Sonntag, K C; Nebhard, N; Haller, G W et al. (2000) Assessment of transduction rates of porcine bone marrow. J Hematother Stem Cell Res 9:721-6
Shimada, H; Germana, S; Sonntag, K C et al. (1999) MHC class II alpha/beta heterodimeric cell surface molecules expressed from a single proviral genome. Hum Gene Ther 10:2397-405
Shimada, H; Alexander, R C; Germana, S et al. (1999) Recombinant retrovirus vectors for the expression of MHC class II heterodimers. Surg Today 29:533-41

Showing the most recent 10 out of 18 publications